Actively Recruiting
Extension Study for Patients Continuing Roche Investigational Medicinal Products from Previous Genentech or F. Hoffmann-La Roche Sponsored Trials
Led by Hoffmann-La Roche · Updated on 2026-10-02
100
Participants Needed
77
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to provide continued treatment to participants with cancer who are still receiving study therapy in a Genentech or F. Hoffmann-La Roche sponsored trial and who lack local access to these treatments. It involves an open-label, multicenter extension phase where eligible patients can continue on investigational therapies following their original study. Participants will continue receiving Roche investigational medicinal products IMPs either as monotherapy or combined with other agents, following the dosing, schedule, and administration used in their parent study. Treatment can continue until disease progression, loss of clinical benefit, unacceptable toxicity, pregnancy, non-compliance, local treatment availability, withdrawal, or study termination by the sponsor. Throughout the study, participants will be monitored for ongoing access to the study drugs and for adverse events using standardized criteria over approximately 10 years. Safety and clinical benefit assessments will guide continuation. The study offers long-term observation to evaluate treatment continuation and tolerability, with participation lasting until one of the stopping criteria is met or up to the study end date.
CONDITIONS
Brief Title
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Research Team
R
Reference Study ID Number: BX44273 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here